Komori
Fuji Pharma (4554) · InitiativeFirst stated

Strengthening the consolidated management structure of the Fuji Pharma Group

First written in FY2017. . Latest entry: FY2017.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Strengthening the Consolidated Management Framework Including SubsidiariesA theme 10 companies write about · 0 as a headwind · 10 as a tailwind

The whole theme swung hardest in 2019: 1 of 6 companies on the "Worse" side.

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2017First statedAnnual report

    「Further enhancement of the consolidated management structure for the 富士製薬工業 Group」

    Strengthening the group-wide consolidated management structure, including its subsidiaries, is identified as a priority issue.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening the consolidated management structure of the Fuji Pharma Group | Fuji Pharma Co.,Ltd. (4554) | Komori